New design and features of Quell 2.0 NeuroMetrix focused largely on two things to differentiate version 2.0: make the device smaller, and more functional with the mobile app for iOS and Android. The ...
June 9 (Reuters) - AstraZeneca (AZN.L), opens new tab said on Friday it had signed an agreement with Quell Therapeutics potentially worth more than $2 billion to develop cell therapies that could cure ...
The Quell 2.0 can’t assess or measure pain, so it needs you to do it, selecting from 0-10 the level of pain you felt generally, when active, while sleeping and how it affected your mood. Using those ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results